This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

A.T. Cross Addition Caps Off Another Successful Year For CuVerro® Antimicrobial Copper

In a move with far-reaching implications for the future of antimicrobial copper, A.T. Cross Company in collaboration with Olin Brass has announced the introduction of the world’s first pen made with a U.S. EPA-registered CuVerro ® bactericidal copper.

Known as the Century ® Copper Pen, the product represents a truly unique and innovative addition to the Cross signature collection of stylish, quality writing instruments. With its Olin Brass supplied CuVerro ® bactericidal touch surface, the pen kills 99.9% of bacteria* within two hours of contact – including MRSA – and delivers continuous and ongoing antibacterial action 24 hours a day. With heightened public awareness for hygiene, the Century Copper Pen with CuVerro® surfaces fits perfectly into everyday life, continuously killing bacteria* on-the-go, at home or in the workplace.

The Century Copper pen also boasts a sleek iconic design, stunning finish, and quality craftsmanship that have established Cross as one of the world’s leading manufacturers of premium writing instruments, timepieces, and personal accessories.

Like all Cross writing instrument products, the Century Copper Pen was designed and engineered in the U.S. and is backed by a lifetime mechanical guarantee. Available in ballpoint, this distinctive pen is priced at $50 SRP and is available to consumers through select retailers in the United States, on-line at, and to business and corporate clients through the U.S. Corporate Gift division of A.T. Cross.

“The Century Copper Pen represents a huge step forward in our efforts to bring CuVerro ® bactericidal touch surfaces into the product mainstream and everyday life,” said Jeff Byrd, Olin Brass Vice President of Marketing & Sales. “It illustrates how simple and sensible an autonomous bacteria control measure can be. And it’s our hope that other manufacturers of everyday personal products will take notice.”

Many already have!

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs